Humana — Oct 30, 2024 release

Insurance segment no change GAAP: approximately $112 billion CenterWell segment no change GAAP: approximately $19 billion Change in year-end medical membership from prior year-end Individual Medicare Advantage Growth of approximately 265,000 Growth of approximately 225,000 Group Medicare Advantage Growth of approximately 35,000 Growth of approximately 45,000 Medicare stand-alone PDP no change Decline of approximately 600,000 State-based contracts Growth of approximately 200,000 Growth of approximately 250,000 State-based contracts guidance includes membership in Florida, Illinois, Indiana, Kentucky, Louisiana, Ohio, Oklahoma, South Carolina, and Wisconsin. Benefit Ratio  Insurance segment no change GAAP: approximately 90% Ratio calculation: benefits expense as a percent of premiums revenues. Operating Cost Ratio Consolidated no change GAAP: approximately 11.4% Ratio calculation: operating costs excluding depreciation and amortization as a percent of revenues excluding investment income. Segment Results Insurance segment income from operations no change GAAP: approximately $1.1 billion Non-GAAP: approximately $1.2 billion Insurance segment Non-GAAP income from operations excludes the projected impact of the exit of employer group commercial medical products business and segment amortization. CenterWell segment Non-GAAP income from operations excludes the projected impact of segment depreciation and amortization. CenterWell segment income from operations no change GAAP: approximately $1.2 billion Non-GAAP: approximately $1.4 billion Effective Tax Rate no change GAAP: approximately 25.2% Non-GAAP: approximately 25.0% Weighted Avg. Share Count for Diluted EPS no change approximately 121 million Cash flows from operations GAAP: approximately $2.75 billion GAAP: approximately $2 billion Capital expenditures GAAP: approximately $600 million GAAP: approximately $800 million 15 Humana Inc. Statistical Schedules and Supplementary Information 3Q24 Earnings Release S-1 Humana Inc. Statistical Schedules and Supplementary Information 3Q24 Earnings Re